K

KaNDy Therapeutics

3 employees

KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$32M

from 4 investors over 4 rounds

K

KaNDy Therapeutics raised $32M on August 29, 2018

Investors: OrbiMed Advisors, Longitude Capital, Forbion and Advent Life Sciences

FAQ